Current Funding Opportunities Update

Read in Browser Current Funding Opportunities NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed) 04/29/2021 The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research to accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on research experiences and mentoring activities. Robert C. Rivers, Ph.D. | RFA-DK-21-023 Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees 04/23/2021 NIH recognizes that the high cost of childcare impacts graduate students and post-doctoral researchers funded through NIH fellowships, and their ability to successfully complete their training and fully participate in the extramural research workforce. Therefore, this Notice announces that NCI, NHGRI, NIA, NIDCR, NIDDK, and NINDS (on behalf of the NIH Blueprint DSPAN) will defray childcare costs to recipients of Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) programs during the F99 phase of the award. Christine Maric-Bilkan, Ph.D.; Cindy Roy, Ph.D. | NOT-CA-21-053 Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain (Admin Supp Clinical Trial Not Allowed) 04/23/2021 The NIH Helping to End Addiction Long TermSM (HEAL) Initiative NIH aims to improve our understanding, management, and treatment of pain by funding high quality scientific research in this relatively understudied area of medicine. For the HEAL Initiative and NIH to meet their long-term goals of providing effective non-opioid options for the treatment of pain conditions and innovative approaches for treating opioid use disorders, it will be necessary to train a new generation of clinical pain researchers. Leveraging HEAL Initiative clinical research programs to train novice researchers and investigators new to pain research in the mechanics, techniques, and best practices of clinical pain research will maximize the impact of HEAL funding for both current and future research endeavors. Increasing the number of individuals trained in high quality clinical pain research is a critical step toward ensuring the highest impact of HEAL, with studies that encompass a broad range of pain conditions and have the potential to include, address the needs of, and positively impact diverse and traditionally under-served patient populations. Rebecca Hommer, M.D. (NINDS)  |  NOT-NS-21-048 Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) 04/22/2021 This Funding Opportunity Announcement (FOA) requests applications for the Kidney Precision Medicine Project (KPMP) - Recruitment Sites (RS) to enroll participants with either acute kidney injury (AKI) and/or chronic kidney disease (CKD) into a longitudinal cohort study and perform protocol-based research kidney biopsies. The RS will collaborate with the Tissue Interrogation Sites (TIS), Kidney Tissue Atlas Coordinating Center (KTACC), and Central Hub (CH) to obtain and evaluate kidney biopsies from participants, create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies. Paul L. Kimmel, M.D.; Afshin Parsa, M.D.; Cindy N. Roy, Ph.D. | RFA-DK-20-026 Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed) 04/22/2021 This Funding Opportunity Announcement (FOA) requests applications for the Kidney Precision Medicine Project (KPMP) - Kidney Tissue Atlas Coordinating Center (KTACC). The KTACC will collaborate with the KPMP Recruitment Sites (RS), Tissue Interrogation Sites (TIS), and Central Hub (CH) to obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) or chronic kidney disease (CKD), create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies. The specific responsibilities of the KTACC will be to clean, harmonize, store, and curate all de-identified KPMP data and (1) use state-of-the-art computational approaches to carry out integrative analyses, and (2) build an interactive Kidney Tissue Atlas with FAIR principles (findable, accessible, interoperable, and reusable) to promote data retrieval, exploration, discovery, and analysis by the community. Eric Brunskill, Ph.D.; Chris Ketchum, Ph.D.; Cindy N. Roy, Ph.D. | RFA-DK-20-027 Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) 04/22/2021 This Funding Opportunity Announcement (FOA) requests applications for the Kidney Precision Medicine Project (KPMP) - Tissue Interrogation Sites (TIS) to analyze human kidney tissue. The TIS will collaborate with the Recruitment Sites (RS), Kidney Tissue Atlas Coordinating Center (KTACC) and Central Hub (CH) to obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) or chronic kidney disease (CKD), create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies. Daniel Gossett, Ph.D.; Chris Ketchum, Ph.D.; Cindy N. Roy, Ph.D. | RFA-DK-20-028 Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) 04/22/2021 This Funding Opportunity Announcement (FOA) requests applications for the Kidney Precision Medicine Project (KPMP) - Central Hub (CH) to support the KPMP cohort, collect and de-identify all existing and new clinical data and samples, and provide scientific, infrastructure, quality control, project management, and administrative support. The CH will collaborate with the Recruitment Sites (RS), Tissue Interrogation Sites (TIS), and Kidney Tissue Atlas Coordinating Center (KTACC) to obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) or chronic kidney disease (CKD), create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies. Tracy Rankin, Ph.D., MPH; Ivonne H. Schulman, M.D.; Cindy N. Roy, Ph.D. | RFA-DK-20-029 View All Funding Opportunities

 

To unsubscribe, update your password, or change your email address visit our Subscriber Preference Page. For any questions or problems with this subscription service, please visit the Subscriber Help Center.

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 Information Way, Bethesda, MD 20892 · 1-800-860-8747